¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"internal ribosomal entry site"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ribosomal frameshift
    ¸®º¸¼ØÇص¶Æ²º¯À§
  • ribosomal RNA
    ¸®º¸¼ØRNA
  • entry exclusion
    ħÀÔ¹èÁ¦
  • entry phenomenon
    ÁøÀÔÇö»ó
  • entry slice phenomenon
    ÁøÀÔÀýÆíÇö»ó
  • antibody-binding site
    Ç×ü°áÇÕºÎÀ§
  • antigen-binding site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-combining site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-recognition site
    Ç׿øÀÎÁöºÎÀ§
  • active site
    Ȱ¼ººÎÀ§
  • binding site
    °áÇÕºÎÀ§
  • combining site
    °áÇÕºÎÀ§
  • donor site
    Á¦°øºÎÀ§, °ø¿©ºÎÀ§
  • fragile site
    Ãë¾àºÎÀ§
  • ligand binding site
    ¸®°£µå°áÇÕºÎÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • site
    ºÎÀ§
  • active site
    Ȱ¼ººÎÀ§
  • antigen-binding site
    Ç׿ø°áÇÕºÎÀ§
  • receptor site
    ¼ö¿ëüºÎÀ§
  • internal
    ¼Ó-, ³»-
  • internal os
    ¼Ó±¸¸Û
  • internal rotation
    ¾ÈÂʵ¹¸², ³»È¸Àü
  • internal version
    ³»Å¾ÆÈ¸Àü(¼ú)
  • internal cerebral vein
    ¼Ó´ë³úÁ¤¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ribosomal RNA
    ¸®º¸¼Ø¾Ë¿£¿¡ÀÌ
  • ribosomal frame shift
    ¸®º¸¼ØÇص¶Æ²º¯ÀÌ
  • entry exclusion
    ¼¼Æ÷³»Ä§Åõ¹èÁ¦
  • entry phenomenon
    ÁøÀÔÇö»ó
  • entry slice effect
    ÁøÀÔÀýÆíÈ¿°ú
  • entry slice phenomenon
    ÁøÀÔÀýÆíÇö»ó
  • root entry zone
    ½Å°æ»Ñ¸®ÁøÀÔºÎ
  • absorption site
    Èí¼öºÎÀ§
  • acceptor site
    ¼ö¿ëºÎÀ§
  • active site
    Ȱ¼ººÎÀ§
  • antibody-binding site
    Ç×ü°áÇÕºÎÀ§
  • antigen-binding site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-combining site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-recognition site
    Ç׿øÀÎÁöºÎÀ§
  • binding site
    °áÇÕºÎÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • RNA, ribosomal
    ¸®º¸¼Ø RNA, rRNA
  • portal of entry
    ħÀÔ±¸(öÕìýÏ¢).
  • portal of entry
    ħÀÔ±¸
  • portal of entry
    ħÀÔ±¸
  • portal of entry
    ħÀÔ?öÕìýÏ¢).
  • absorption site
    Èí¼öÁ¡
  • acceptor site
    ¼ö¿ëºÎÀ§
  • active site
    Ȱ¼ºÀÚ¸®.
  • antibody binding site
    Ç×ü°áÇÕºÎÀ§
  • antibody combining site
    Ç×ü°áÇÕºÎ(ù÷ô÷Ì¿ùêÝ»).
  • antigen binding site
    Ç׿ø°áÇÕºÎÀ§
  • antigen combining site
    Ç׿ø°áÇպΠ(¡­Ì¿ùêÝ»).
  • antigen recognition site
    Ç׿ø½Äº°ºÎ.
  • fundic site
    ÀڱùٴÚÀÓ½Å
  • placental site trophoblastic tumor
    ŹݺÎÂøºÎÀ§ À¶¸ð»óÇǼºÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • internal ribosomal entry site (IRES)
    ³»ºÎ ¸®º¸¼Ø °áÇÕºÎÀ§
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ribosomal RNA
    ¸®º¸¼Ø¸®º¸ÇÙ»ê(¡­ú·ß«).
  • ribosomal frame shift
    ¸®º¸¼Ø ÇØµ¶Æ² º¯È¯
  • entry exclusion
    ¼¼Æ÷³»Ä§Åõ¹èÁ¦
  • entry phenomenon
    ÁøÀÔ Çö»ó
  • entry slice effect
    À¯ÀÔ ´Ü¸é È¿°ú
  • entry slice phenomenon
    À¯ÀÔ ´Ü¸é Çö»ó
  • portal of entry
    ħÀÔ±¸(öÕìýÏ¢).
  • portal of entry
    ħÀÔ?öÕìýÏ¢).
  • portal of entry
    ħÀÔ±¸
  • portal of entry
    ħÀÔ±¸
  • result entry
    °á°úÀÔ·Â
  • slice entry phenomenon
    ÀýÆí ÀÔ±¸ Çö»ó
  • absorption site
    Èí¼öÁ¡
  • acceptor site
    ¼ö¿ëºÎÀ§
  • active site
    Ȱ¼ºÀÚ¸®.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Variations of site
    À§Ä¡º¯ÀÌ
    [¿¾ ¿ë¾î] À§Ä¡ÀÌ»ó
  • Corporal site
    ÀڱøöÅëÀÓ½Å
    [¿¾ ¿ë¾î] ÀÚ±ÃüºÎ
  • Absorption site
    Èí¼öÁ¡
    [¿¾ ¿ë¾î] Èí¼öÃÊÁ¡
  • Fundic site
    ÀڱùٴÚÀÓ½Å
    [¿¾ ¿ë¾î] ÀÚ±ÃÀúºÎ
  • Definitive site
    Âø»óÀÚ¸®
    [¿¾ ¿ë¾î] À§Ä¡¼±Á¤
  • (Internal auditory branch)
    (¼Ó±Í±æ°¡Áö)
    [¿¾ ¿ë¾î] ³»À̵µÁö
  • (Internal occipital crest)
    (¼ÓµÚÅë¼ö»À´É¼±)
    [¿¾ ¿ë¾î] ³»Èĵθª
  • INTERNAL GENITAL ORGANS OF MALE
    ³²¼º¼Ó»ý½Ä±â°ü
    [¿¾ ¿ë¾î] ³²¼º ³»»ý½Ä±â
  • Internal plate of optic cup
    ´«¼úÀܼӯÇ
    [¿¾ ¿ë¾î] ¾È¹è³»ÆÇ
  • Posterior internal vertebral venous plexus
    µÚ¼ÓôÁÖÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Èij»Ãß°ñÁ¤¸ÆÃÑ
  • Internal periosteal layer
    »À¸·¼ÓÆÇ
    [¿¾ ¿ë¾î] ³»°ñ¸·ÆÇ
  • Internal
    ¼Ó [³»]
    [¿¾ ¿ë¾î] ³»
  • Internal thoracic artery
    ¼Ó°¡½¿µ¿¸Æ
    [¿¾ ¿ë¾î] ³»È䵿¸Æ
  • Internal thoracic veins
    ¼Ó°¡½¿Á¤¸Æ
    [¿¾ ¿ë¾î] ³»ÈäÁ¤¸Æ
  • Internal branch
    ¼Ó°¡Áö
    [¿¾ ¿ë¾î] ³»Áö
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • internal autoinfection
    ³»ºÎÀÚ°¡°¨¿°
  • internal parasitism
    ³»ºÎ±â»ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • entry site
    ÁøÀÔ(òäìý) ÀÚ¸®
  • internal resolution site
    ³»°áÁ¤(Ү̿ïÜ) ÀÚ¸®
  • A-site-P-site moel
    AÀÚ¸® PÀÚ¸® ¸ðµ¨
  • precursor ribosomal RNA
    ¶óÀ̺¸¼Ø RNA
  • pre-ribosomal RNA
    Àü±¸(îñÏÌ)¶óÀ̺¸¼Ø RNA
  • ribosomal DNA
    ¶óÀ̺¸¼Ø DNA
  • ribosomal particle
    ¶óÀ̺¸¼Ø ÀÔÀÚ(Ø£í­)
  • ribosomal precursor RNA
    ¶óÀ̺¸¼Ø Àü±¸(îñÏÌ) RNA
  • ribosomal protein
    ¶óÀ̺¸¼Ø ´Ü¹éÁú(Ó±ÛÜòõ)
  • ribosomal RNA
    ¶óÀ̺¸¼Ø RNA
  • ribosomal sieve
    ¶óÀ̺¸¼ØÃ¼(ô÷)
  • ribosomal stalling
    ¶óÀ̺¸¼Ø Áöü(ò¶ô÷)
  • ribosomal subparticle
    ¶óÀ̺¸¼Ø ¾ÆÀÔÀÚ(䬨£í­)
  • ribosomal subunit
    ¶óÀ̺¸¼Ø ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • ribosomal subunit exchange
    ¶óÀ̺¸¼Ø ¾Æ´ÜÀ§(ä¬Ó¤êÈ) ±³È¯(Îßüµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • site
    À§Ä¡,»çÀÌÆ®
  • web site
    À¥½ÎÀÌÆ®
  • entry phenomenon
    ÁøÀÔÇö»ó
  • entry slice effect
    À¯ÀԴܸéÈ¿°ú
  • entry slice phenomenon
    À¯ÀԴܸéÇö»ó
  • slice entry phenomenon
    ÀýÆíÀÔ±¸Çö»ó
  • internal
    ³»ÀÇ, ³»ºÎÀÇ
  • internal acoustic canal
    ³»À̵µ
  • internal anal sphincter
    ³»Ç×¹®°ý¾à±Ù
  • internal capsule
    ³»Æ÷
  • internal carotid artery
    ³»°æµ¿¸Æ
  • internal ear
    ³»ÀÌ
  • internal echo
    ³»ºÎ¿¡ÄÚ
  • internal fistula
    ³»·ç
  • internal focus
    ³»ºÎÃÊÁ¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
POE pediatric orthopedic examination; physician order entry; point of entry; polyoxyethylene; postoperat...
FS factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher...
IC icteric, icterus; immune complex; immunoconjugate; immunocytochemistry; immunocytotoxicity; impedanc...
IM idiopathic myelofibrosis; immunosuppressive method; implementation monitoring; Index Medicus; indome...
IRS immunoreactive secretion; infrared spectrophotometry; insulin receptor species; insulin receptor sub...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IRES internal ribosomal entry site
IRES Internal Ribosome Entry Site
IRES Internal Ribosome Entry Segments
RBS ribosomal binding site
Site 1 site
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ribosomal frame shift
    ¸®º¸¼Ø ÇØµ¶ Ʋ º¯È¯
  • dorsal root entry zone

    dorsal root ganglion (¹è±Ù ½Å°æÀý, Èı٠½Å°æÀý

  • entry exclusion
    ¼¼Æ÷³» ħÅõ ¹èÁ¦
  • entry slice effect
    À¯ÀÔ ´Ü¸é È¿°ú
  • slice entry phenomenon
    ÀýÆí ÀÔ±¸ Çö»ó
  • antigen binding site
    Ç׿ø °áÇÕ ºÎÀ§
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ 3Â÷ ±¸Á¶»ó H ¼â¿Í L ¼âÀÇ °¡º¯¿µ¿ª¿¡¼­ ±¸¼ºµÇ¾î ÀÖ´Â Ç׿ø°ú °áÇÕÇÏ´Â ºÎÀ§.
  • antigen combining site
    Ç׿ø °áÇÕºÎ
  • antigen recognition site
    Ç׿ø ½Äº°ºÎ
  • cleavage site
    ºÐ¿­ ºÎÀ§
  • combining site
    °áÇÕºÎ
  • electrophilic site
    Ä£ÀüÀÚ ¹ÝÀÀ¹°
  • molecular site
    ºÐÀÚ À§
  • receptor site
    ¼ö¿ëü ºÎÀ§, ¼ö¿ëºÎ
    ƯÁ¤ÇÑ »ý¹°ÇÐÀû ¹ÝÀÀÀ» ÃÊ·¡ÇÏ´Â ºÐÀÚ °áÇÕÀÌ ÀϾ´Â ƯÁ¤ ºÎÀ§.
  • recognition site
    ÀÎ½Ä ºÎÀ§
  • site
    À§Ä¡, »çÀÌÆ®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
DNA entry nuclease <chemical> Mw 75kda; from membranes of competent bacillus subtilis cells; shows DNA-binding and nuclease activity; believed to be involved in entry of DNA into competent b subtilis cells
(26 Jun 1999)
entry Origin: OE. Entree, entre, F. Entree, fr. Entrer to enter. See Enter, and cf. Entree.
1. The act of entering or passing into or upon; entrance; ingress; hence, beginnings or first attempts; as, the entry of a person into a house or city; the entry of a river into the sea; the entry of air into the blood; an entry upon an undertaking.
2. The act of making or entering a record; a setting down in writing the particulars, as of a transaction; as, an entry of a sale; also, that which is entered; an item. "A notary made an entry of this act." (Bacon)
3. That by which entrance is made; a passage leading into a house or other building, or to a room; a vestibule; an adit, as of a mine. "A straight, long entry to the temple led." (Dryden)
4. The exhibition or depositing of a ship's papers at the customhouse, to procure license to land goods; or the giving an account of a ship's cargo to the officer of the customs, and obtaining his permission to land the goods. See Enter, 8, and Entrance.
5.
5. The actual taking possession of lands or tenements, by entering or setting foot on them. A putting upon record in proper form and order.
The act in addition to breaking essential to constitute the offense or burglary. Bill of entry. See Bill. Double entry, Single entry. See Bookkeeping. Entry clerk, a writ issued for the purpose of obtaining possession of land from one who has unlawfully entered and continues in possession.
Source: Websters Dictionary
(01 Mar 1998)
entry zone The area of the dorsal funiculus of the spinal cord, medial to the tip of the posterior horn, in which the entering fibres of the posterior nerve root divide into ascending and descending branches.
(05 Mar 2000)
ribosomal neutral proteinase <enzyme> Ribosomal serine proteinase from rat liver ribosomes in cryptic form
Registry number: EC 3.4.21.52
Synonym: cathepsin r
(26 Jun 1999)
ribosomal protein <protein> Proteins present within the ribosomal subunits. In prokaryotes there are 31 proteins in the large subunit and 21 in the small subunit. Eukaryotic subunits have 50 (large subunit) and 33 (small subunit) proteins.
(18 Nov 1997)
ribosomal proteins Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits.
(12 Dec 1998)
ribosomal protein s6 kinase <enzyme> A protein serine/threonine kinase which is involved in cell transformation by polyoma virus and is connected to the expression of igf2. The immunosuppressant rapamycin inhibits the activation of the kinase, leading to reduced translation of certain mRNAs and a decrease in protein synthesis.
Registry number: EC 2.7.10.-
(12 Dec 1998)
ribosomal protein S6 kinase kinase <enzyme> Isolated from unfertilised xenopus eggs; a 41 kD enzyme that is associated, in vivo, with phosphorylation on threonine and tyrosine residues and, in vitro, with phosphorylation on serine as well
Registry number: EC 2.7.1.-
Synonym: rsk kinase
(26 Jun 1999)
ribosomal RNA <molecular biology> A nucleic acid found in all living cells. Plays a role in transferring information from DNA to the protein-forming system of the cell.
(16 Dec 1997)
RNA, ribosomal A component of ribosomes, ribosomal RNA functions as a non-specific site for making polypeptides. Ribosomal RNA is abbreviated rrna.
(12 Dec 1998)
RNA, ribosomal, 16s Constituent of 30s subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16s rrna is involved in initiation of polypeptide synthesis.
(12 Dec 1998)
RNA, ribosomal, 18s Constituent of the 40s subunit of eukaryotic ribosomes. 18s rrna is involved in the initiation of polypeptide synthesis in eukaryotes.
(12 Dec 1998)
RNA, ribosomal, 23s Constituent of 50s subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23s rrna is involved in the initiation of polypeptide synthesis.
(12 Dec 1998)
RNA, ribosomal, 28s Constituent of the 60s subunit of eukaryotic ribosomes. 28s rrna is involved in the initiation of polypeptide synthesis in eukaryotes.
(12 Dec 1998)
RNA, ribosomal, 5.8s Constituent of the 60s subunit of eukaryotic ribosomes. 5.8s rrna is involved in the initiation of polypeptide synthesis in eukaryotes.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ribosomal RNA
    ¸®º¸¼Ø ¸®º¸ ÇÙ»ê(¼¼Æ÷ÁúÀÇ Çٴܹé ÀÔÀÚ ¾È¿¡ ÀÖ´Â ¸®º¸ ÇÙ»ê)
  • site
    À§Ä¡
  • caravan park (site)
    À̵¿ÁÖÅÃ(Æ®·¹ÀÏ·¯) ÁÖÂ÷Àå
  • ceru(s)site
    ¹é¿¬±¤
  • county seat (site)
    ±ºÃ» ¼ÒÀçÁö;±ºÀÇÇàÁ¤ Áß½ÉÁö
  • launching site
    ¹ß»ç±âÁö
  • receptor site
    ¼¼Æ÷³» ¼ö¿ë ¿µ¿ª
  • restriction site
    Á¦ÇÑ ºÎÀ§(Á¦ÇÑ È¿¼Ò°¡ Àý´ÜÇÏ´Â µÎ ÁÙ »ç½½ DNA»óÀÇ ºÎÀ§)
  • site
    À§Ä¡;Àå¼Ò;¿ëÁö;ºÎÁö !
  • entry
    ÀÔ±¸
  • internal
    ³»ºÎÀÇ; º»ÁúÀûÀÎ; ±¹³»ÀÇ
  • Internal Revenue Service
    (¹Ì)±¹¼¼Ã»
  • double entry
    º¹½Ä ºÎ±â¹ý
  • entry
    µé¾î°¨;ÀÔÀå;Âü°¡;ÀÔ±¸;±âÀÔ;Á¡°Å
  • entry permit
    ÀÔ±¹ Çã°¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á